Abnormal visuomotor processing in schizophrenia by Robson, Siân E. et al.
                             Elsevier Editorial System(tm) for NeuroImage: Clinical 
                                  Manuscript Draft 
 
 
Manuscript Number: NICL-15-50R2 
 
Title: Abnormal visuomotor processing in schizophrenia  
 
Article Type: Regular Article 
 
Section/Category: Psychiatry 
 
Corresponding Author: Prof Peter G Morris,  
 
Corresponding Author's Institution: University of Nottingham 
 
First Author: Siân Ellen Robson, PhD 
 
Order of Authors: Siân Ellen Robson, PhD; Matthew J Brookes; Emma L Hall; Lena Palaniyappan; 
Jyothika Kumar; Michael Skelton; Nikolaos G Christodoulou; Ayaz Qureshi; Fiesal Jan; Mohammad Z 
Katshu; Elizabeth B Liddle; Peter F Liddle; Peter G Morris 
 
Abstract: Subtle disturbances of visual and motor function are known features of schizophrenia and 
can greatly impact quality of life; however, few studies investigate these abnormalities using simple 
visuomotor stimuli.  In healthy people, electrophysiological data show that beta band oscillations in 
sensorimotor cortex decrease during movement execution (event-related beta desynchronisation 
(ERBD)), then increase above baseline for a short time after the movement (post movement beta 
rebound (PMBR)); while in visual cortex, gamma oscillations are increased throughout stimulus 
presentation.  In this study, we used a self-paced visuomotor paradigm and magnetoencephalography 
(MEG) to contrast these responses in patients with schizophrenia and control volunteers.  We found 
significant reductions in the peak-to-peak change in amplitude from ERBD to PMBR in schizophrenia 
compared with controls.  This effect was strongest in patients who made fewer movements, whereas 
beta was not modulated by movement in controls.  There was no significant difference in the amplitude 
of visual gamma between patients and controls.  These data demonstrate that clear abnormalities in 
basic sensorimotor processing in schizophrenia can be observed using a very simple MEG paradigm. 
 
 
 
 
 
UNITED KINGDOM  • CHINA  • MALAYSIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Editor 
 
Abnormal visuomotor processing in schizophrenia: An MEG study 
 
Please find attached our revised paper for consideration for publication in 
NeuroImage Clinical. We thank you and the reviewers for your time and effort in 
reviewing our manuscript. We have revised our manuscript in accordance with the 
second round of reviewer comments, and we feel it is significantly improved as a 
result. We look forward to your response. 
 
Yours sincerely 
 
Professor Peter Morris 
Sir Peter Mansfield Magnetic  
Resonance Centre, 
School of Physics & Astronomy 
University Park 
Nottingham 
NG7 2RD 
 
Tel +44(0)115 951 4750 
Fax +44(0)115 951 5166 
 
Email: peter.morris@nottingham.ac.uk 
www.magres.nottingham.ac.uk 
 
Professor Peter G Morris 
Head of Sir Peter Mansfield 
Magnetic Resonance Centre 
 
 
NeuroImage Clinical Editor 
 
 
 
 
 
 
19th February 2015 
1. Cover Letter
Manuscript: Abnormal visuomotor processing in schizophrenia 
 
Highlights:  
 Visual and motor deficits in schizophrenia are rarely investigated. 
 We use MEG to non-invasively assess the neural basis of these deficits. 
 Patients showed abnormalities in neuronal oscillations in motor cortex. 
 Beta band power, reflecting cortical inhibition, was reduced after movements. 
 Increased movement frequency may be a behavioural compensation for this reduction. 
 
 
*4. Highlights (for review)
Abnormal visuomotor processing in schizophrenia 
S. Robson, M. Brookes, E. Hall, L. Palaniyappan, J. Kumar, M. Skelton, N. Christodoulou, A. 
Qureshi, F. Jan, M. Katshu, E. Liddle, P. Liddle and P. Morris 
Response to Reviewer 
 
We thank the reviewer for their comments. In what follows, text from our manuscript is in bold 
typeface; additions to our manuscript are in bold italic typeface. 
The referee raises the important point that the relationship between the deficit in post-movement 
beta rebound and a composite score for illness severity might be mediated by a selective association 
with specific clinical features.  We had tested the association with a factor score representing a 
weighted combination of clinical features that we had previously identified as features that persist 
during a stable phase of illness, and had shown to be related to disordered connectivity 
(Palaniyappan et al, 2013).  We reported association with this single measure to avoid the problem 
of multiple comparisons.  This composite score included measures of symptoms, and cognitive, 
occupational and social function. 
   
Although much evidence from prior studies suggests that distinguishable pathological processes  are 
involved in the three symptom clusters characteristic of schizophrenia, all three clusters of 
symptoms are associated with impairment of cognitive, occupational and social function in the 
stable phase of illness, and furthermore, a composite score of these clinical features is associated 
with disordered connectivity (Palaniyappan et all, 2013) suggesting that they are associated with a 
shared pathological feature that predisposes to persistence. Nonetheless we agree that an 
examination of the degree to which different clinical features contribute to the factor is warranted.    
 
We have added a clause to the description of the patient sample (section 2.1) to emphasise that 
they were studied during a stable phase of illness. 
 
All patients were in a stable phase of illness with no change in antipsychotic, antidepressant, or 
mood- stabilizing medications, nor a change of more than 10 points in occupational and social 
function scored according to the Social and Occupational Function Assessment Scale (SOFAS) (APA 
1994), in the 6 weeks prior to the study.   
 
In the results section we have included a table giving the loadings of the various clinical features on 
the factor score. 
 
Table 4: Loadings on the first factor derived from factor analysis of clinical features hypothesised 
to reflect current severity of illness: reality distortion, psychomotor poverty and disorganisation 
syndromes from the Signs and Symptoms of Psychotic Illness (SSPI) scale (Liddle, 2002); and scores 
from the Digit Symbol Substitution Test (DSST; Wechsler, 1944) and the Social and Occupational 
Function Assessment Scale (SOFAS; APA, 1994). 
Illness severity 
measure 
Loading on severity 
of persisting illness 
factor 
Reality distortion 0.72 
Psychomotor poverty 0.61 
Disorganisation 0.58 
DSST -0.37 
SOFAS -0.67 
*6. Response to Reviews
We have also modified the caption to figure 5 to emphasize that the clinical features represent a 
score for severity of persisting clinical features.  
 
Figure 5: Correlation between PMBR and severity of persisting psychotic illness.  The amplitude of 
the post-movement beta rebound showed a significant negative correlation with a measure of 
overall psychotic illness severity persisting during a stable phase of illness in the patient group. 
 
We have modified the discussion as follows.  
 
The PMBR was inversely correlated with a score of overall severity of psychotic illness assessed 
during a stable phase of the illness.  The scores for the three core syndromes of schizophrenia 
loaded positively on the illness severity measure, while social, occupational and cognitive function 
loaded negatively on it (Table 4).  The magnitude of the DSST loading is lower than for the other 
items, but DSST score was retained because the set of items were selected a priori as a measure of 
illness severity (Palaniyappan et al., 2013) and a meta-analysis of cognitive impairments in 
schizophrenia has shown that the DSST quantifies an inefficiency of information processing that is 
an important feature of schizophrenia (Dickinson et al, 2007).  
 
Similar to previous studies (e.g. Liddle, 1987b), the three syndrome scores showed low mutual 
correlations (0.033 to 0.33; p<.05), but all three loaded heavily on a single factor, along with the 
SOFAS and DSST scores, indicating that they are associated with a latent variable likely to reflect 
severity of illness.  Scores on this composite measure of overall current severity of psychotic illness 
exhibited a significant negative Pearson correlation with the PMBR in the patient group (R=-0.52; 
p=.015; Figure 5), with no correlation between illness severity and ERBD or visual gamma (R=-.18 
and .06 respectively; p=ns).  Therefore, those patients with higher severity scores had stronger 
core symptoms and lower levels of function and these were also the patients who showed the 
smallest beta rebound. 
 
Additional references 
Liddle PF (1987b) The symptoms of chronic schizophrenia: a re-examination of the positive-
negative dichotomy.  British Journal of Psychiatry,  151: 145-151. 
Dickinson D, Ramsey ME, Gold JM. (2007) . Overlooking the obvious: a meta-analytic comparison 
of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 
64(5):532-42. 
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Abstract 
Subtle disturbances of visual and motor function are known features of schizophrenia and 
can greatly impact quality of life; however, few studies investigate these abnormalities using 
simple visuomotor stimuli.  In healthy people, electrophysiological data show that beta band 
oscillations in sensorimotor cortex decrease during movement execution (event-related 
beta desynchronisation (ERBD)), then increase above baseline for a short time after the 
movement (post movement beta rebound (PMBR)); while in visual cortex, gamma 
oscillations are increased throughout stimulus presentation.  In this study, we used a self-
paced visuomotor paradigm and magnetoencephalography (MEG) to contrast these 
responses in patients with schizophrenia and control volunteers.  We found significant 
reductions in the peak-to-peak change in amplitude from ERBD to PMBR in schizophrenia 
compared with controls.  This effect was strongest in patients who made fewer movements, 
whereas beta was not modulated by movement in controls.  There was no significant 
difference in the amplitude of visual gamma between patients and controls.  These data 
demonstrate that clear abnormalities in basic sensorimotor processing in schizophrenia can 
be observed using a very simple MEG paradigm. 
 
Key words 
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1.  Introduction 
Schizophrenia is a psychiatric disorder characterised by a range of symptoms including 
hallucinations, delusions, disorganised thought and behaviour, and reduced cognitive and 
emotional capacity.  Research tends to focus on these core symptoms; however, patients 
also experience impairments in more basic sensorimotor processes (Bombin et al., 2005; 
Butler et al., 2001; Vrtunski et al., 1986).  Abnormalities in motor function have been noted 
since the earliest descriptions of the disorder (Kraepelin, 1919) and are a well-accepted 
feature of schizophrenia, with the vast majority of patients exhibiting at least one type of 
motor symptom (Peralta et al., 2010; Walther et al., 2012).  These symptoms include 
involuntary movements, catatonia, Parkinsonism and deficits in the production of both 
simple and complex movements such as coordination, reflexes and motor sequencing 
(Bombin et al., 2005; Kraepelin, 1919; Vrtunski et al., 1989).  Similarly, patients with 
schizophrenia exhibit deficits in low-level visual function, particularly in processing stimuli of 
low spatial frequencies, as evidenced by reduced contrast sensitivity, centre-surround 
interference and abnormal motion perception (Butler et al., 2001; Cadenhead et al., 2013; 
Keri et al., 2002; Slaghuis, 1998).   
 
There is significant evidence that these subtle abnormalities in basic sensorimotor 
processing are present in childhood, at the onset of core symptoms and in relatives of 
individuals with schizophrenia (Chen et al., 2000; Walther et al., 2012; Whitty et al., 2009), 
indicating that they are likely to be inherent to the disorder rather than being a 
consequence of long-term exposure to medication.  Importantly, visual and motor deficits, 
as well as other neurological abnormalities, correlate with the primary symptoms of 
schizophrenia such as affective flattening, apathy and disorganisation (Bombin et al., 2005; 
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Jahn et al., 2006; Liddle, 1987; Peralta et al., 2010) , and with illness severity (Jahn et al., 
2006), social functioning (Dickerson et al., 1996; Jahn et al., 2006; Lehoux, 2003) and 
functional outcome (Boden et al., 2014; Javitt, 2009), suggesting they could be used as a 
biomarker for the disorder.   
 
Understanding the neuronal basis of these symptoms could therefore ultimately contribute 
to development of treatments permitting improved quality of life; however, at present the 
neuronal mechanisms underlying sensorimotor processing deficits in schizophrenia are not 
known.  It is likely that different types of symptoms have different aetiologies (Chen et al., 
2000).  Visual deficits have been reported to be due to abnormalities in lower-level visual 
pathways, particularly in magnocellular neurons (Butler et al., 2001).   These neurons rely on 
N-methyl-D-aspartate (NMDA)-type glutamate receptors, which may show dysfunctional 
transmission in schizophrenia (Javitt, 2009).  A review of motor symptoms and their 
potential aetiology by Walther and Strik (2012) describes reductions in volume of the 
anterior cingulate cortex and midbrain structures (putamen, caudate and thalamus), and 
disturbed gamma-aminobutyric acid (GABA)-ergic neurotransmission in these areas and the 
primary motor cortex.  Neuroimaging techniques are of great use in measuring the 
structural and physiological abnormalities that may contribute to sensorimotor 
abnormalities in schizophrenia. 
 
Magnetoencephalography (MEG) allows non-invasive inference of current flow in neuronal 
cell assemblies through measurement of extracranial magnetic fields.  MEG signals are 
dominated by oscillations, which result from rhythmic activity in large populations of 
neurons.  Neuronal oscillatory responses to visual and motor stimulation have been well 
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characterised in healthy volunteers: in motor cortex, the amplitude of beta (13-30Hz) 
oscillations decreases during movement (event-related beta desynchronisation (ERBD)) and 
increases above baseline on movement cessation (post-movement beta rebound (PMBR)), 
returning to baseline ~4s after movement offset (Pfurtscheller et al., 1999).  In visual cortex, 
a decrease in alpha (8-12Hz) oscillatory amplitude occurs alongside a concomitant increase 
in gamma (30-70Hz) oscillations (Siegel et al., 2010).  Notably, individual differences in the 
amplitude of motor beta oscillations correlate with electromyogram measures of muscle 
control (Jain et al., 2013; Mima et al., 2000), whilst visual gamma oscillations correlate with 
orientation discrimination performance (Edden et al., 2009).  Measurement of these 
electrophysiological features is therefore likely to offer insight into the neuronal basis of 
motor and visual deficits in schizophrenia. 
 
Previous studies have identified electrophysiological visuomotor abnormalities in 
schizophrenia and related disorders: Wilson et al (2011) showed that adolescents with early-
onset psychosis exhibit enhanced ERBD and reduced PMBR while conducting a motor task.  
Since beta oscillations are thought to reflect inhibition (Cassim et al., 2001; Gaetz et al., 
2011), reduced amplitude may reflect a greater degree of processing required to plan and 
execute movements in patients.  In visual cortex, either no change (Uhlhaas et al., 2006) or a 
reduction in amplitude (Grutzner et al., 2013) and frequency (Spencer et al., 2004) of 
gamma oscillations have been reported in schizophrenia.  However, available data are 
sparse and typically relate to complex stimuli (e.g. faces or Gestalt stimuli) that require 
integration of visual features.  The question therefore remains of whether patients with 
schizophrenia show abnormalities in oscillations reflecting low-level visual and motor 
processing.  In this study, we measure ERBD and PMBR in sensorimotor cortex and gamma 
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oscillations in visual cortex during a simple visuomotor task, to test the hypothesis that 
these well characterised phenomena are perturbed in schizophrenia. 
 
2.  Methods 
2.1.  Participants.  The study received ethical approval from the National Research Ethics 
Service and all participants gave written informed consent.  The patient group was recruited 
from community-based mental health teams in Nottinghamshire, Derbyshire and 
Lincolnshire, United Kingdom.  Diagnoses were made in clinical consensus meetings through 
a review of case files and a standardized clinical interview (Signs and Symptoms of Psychotic 
Illness or SSPI (Liddle, 2002)) in accordance with the procedure of Leckman et al. (1982).  All 
patients were in a stable phase of illness with no change in antipsychotic, antidepressant, or 
mood- stabilizing medications, nor a change of more than 10 points in occupational and 
social function scored according to the Social and Occupational Function Assessment Scale 
(SOFAS) (APA 1994), in the 6 weeks prior to the study.  Patients were taking a range of 
psychotropic medication, with a mean defined daily dose (DDD) of 1.8 (SD 1.3).  Controls 
were selected to match the patient group in terms of demographic variables.  There were 
seventeen male and six female patients with schizophrenia and the same number of male 
and female controls.  There was no significant difference between the ages of the two 
groups (patients and controls’ mean age 26.8 (SD 7.0) and 26.7 (SD 7.2), respectively; 
U=264.5, p=1.0).  Groups were also matched for socio-economic background using the 
National Statistics Socio-Economic Classification (NS-SEC) self-coded method.  NS-SEC scores 
are given in Table 1 and did not differ significantly between groups (χ2(4, N=46)=2.3, p=.69).  
All participants had normal or corrected to normal vision. 
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 NSSEC score 1 2 3 4 5  Mean SD 
Number of 
participants 
Schizophrenia 13 1 4 1 4  2.2 1.6 
Controls 11 2 5 3 2  2.3 1.4 
Table 1.  National Statistics Socio-Economic Classification (NS-SEC) scores. 
 
Participant Drug (dose) Total DDD 
1 Risperidone (25mg/1 to 2 weeks); Citalopram (20mg) 1.66 
2 Risperidone (2mg) 0.4 
3 Diazepam (2mg); Mirtazapine (45mg); Aripiprazole (20mg); Zopiclone (7.5mg) 4 
4 Amisulpride (200mg); Clozapine (275mg) 1.42 
5 Olanzapine (15mg) 1.5 
6 Olanzapine (25mg); Sertraline (50mg) 3.5 
7 Lofepramine (70mg) 0.67 
8 Paliperidone (100mg/month); Risperidone (3mg) 1.15 
9 Mirtazapine (45mg); Aripiprazole (20mg); Pregabalin (150mg) 3.3 
10 Clozapine (400mg) 1.3 
11 Olanzapine (5mg) 0.5 
12 Aripiprazole (20mg) 1.33 
13 Quetiapine (200mg) 0.5 
14 Clozapine (350mg), Sulpiride (200mg) 1.42 
15 Aripiprazole (5mg) 0.33 
16 Risperidone (2mg), Sertraline (100mg) 2.4 
17 Clozapine (400mg), Sulpiride (400mg) 1.8 
18 Sertraline (200mg), Lithium (1g), Clozapine (200mg) 5.77 
19 Zuclopenthixol (20mg) 2.86 
20 Olanzapine (20mg) 2 
21 Quetiapine (200mg), Procyclidine (5mg), Venlafaxine (75mg), Modecate 
(25mg/2 weeks) 2.45 
22 Clozapine (300mg) 1 
23 Aripiprazole (10mg) 0.67 
Mean 1.82 
SD 1.34 
Table 2.  Details of patients’ pharmacological treatment including the drug, its dose and the 
total defined daily dose (DDD) of psychotropic medication for each participant.  Doses are 
per day unless given as a depot, in which case the frequency is specified. 
 
2.2 Symptom severity measurement.  In order to derive a score for overall severity of 
psychotic illness in the patient group, we followed the procedure employed by Palaniyappan 
et al. (2013).  We computed the first principle component of: the scores for the three 
characteristic syndromes of schizophrenia (reality distortion, psychomotor poverty and 
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disorganization) assessed using the SSPI; speed of cognitive processing assessed using a 
variant of the Digit Symbol Substitution Test (Wechsler, 1944); and scores from the Social 
and Occupational Function Scale (SOFAS; (APA, 1994)).  Unlike Palaniyappan et al. (2013), 
who focussed on chronic symptom burden, we did not include duration of illness in our 
measure of current illness severity. 
 
2.3.  Paradigm.  The task comprised visual stimulation with a centrally-presented maximum 
contrast vertical square wave grating (3 cycles per degree), which subtended an 8° visual 
angle and was displayed behind a red fixation cross on a mean luminance background.  The 
grating was presented for two seconds followed by a seven second fixation only baseline 
period.  Participants were instructed to press a button with their right index finger regularly 
but as many times as they chose during the 2s presentation of the grating, though ensuring 
that they didn’t press so vigorously as to cause their arm to move.  There were 45 trials, 
giving a total task length of seven minutes.  A short practice of the task was given outside 
the scanner.  Stimuli were generated on a PC using MATLAB (The Mathworks, Inc., Natick, 
MA) and were back-projected via a mirror system onto a screen inside a magnetically 
shielded room at a viewing distance of 46cm.  All participants were scanned in a supine 
position.  Right index finger button presses were recorded via a response pad (Lumitouch 
Photon Control Response System). 
 
2.4.  Data acquisition and analysis.  MEG data were obtained using a 275 channel whole 
head CTF system (MISL, Coquitlam, Canada), with four channels switched off due to 
excessive sensor noise.  Twenty-nine reference channels were also recorded for noise 
cancellation purposes and the primary sensors were analysed as synthetic third order 
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gradiometer measurements (Vrba et al., 2001).  Data were acquired at a sampling frequency 
of 600Hz with a 150Hz low-pass anti-aliasing hardware filter.  The position of the head 
within the MEG helmet was measured continuously during the recording by energising three 
electromagnetic head position indicator coils located at the nasion and left and right pre-
auricular points, allowing continuous head movement tracking throughout the acquisition.  
A 3-dimensional digitisation of the head shape and fiducial locations was obtained using an 
Isotrak (Polhemus Inc., Vermont) system prior to the MEG measurement.  All participants 
also underwent an anatomical MRI scan, acquired using a Philips Achieva 7T system with a 
volume transmit and 32 channel receive head coil.  A 1mm isotropic image was obtained 
using an MPRAGE sequence (TE/TR = 3/7ms, FA=8°).  Coregistration of the MEG sensor 
geometry to the anatomical MR image was achieved by fitting the digitised head surface to 
the equivalent head surface extracted from the anatomical MR image. 
 
Initially, MEG data were inspected visually.  Common sources of interference, for example 
the magnetomyogram, magnetooculogram and magnetocardiogram, have well 
characterised neuromagnetic signatures which are easily identified by an experienced 
operator.  Here, any trials deemed to contain excessive interference generated via such 
sources were removed from that individual’s data (see also Gross et al. (2013)).  Head 
movement was assessed via continuous head localisation and any trials in which the head 
was found to be more than 7mm (Euclidean distance) from the starting position were 
excluded.  This left an average of 42 trials (SD 3.6) in controls and 38 (SD 4.9) trials in 
patients.  Lead fields were computed individually for each participant using a multiple-local-
sphere head model (Huang et al., 1999) and the dipole model derived by Sarvas (1987).  A 
scalar beamformer (synthetic aperture magnetometry (Robinson et al., 1998)) was used to 
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project extracranial field signals into source space.  Images showing the spatial signature of 
task induced oscillatory power change were computed in the beta (13-30Hz) and gamma 
(30-70Hz) ranges.  In both cases, an active window of 0.5-1.8s was compared to a control 
window spanning 7.0-8.3s, relative to stimulus onset.  Covariance matrices for beamformer 
reconstruction were calculated individually for the active and control windows, giving even 
amounts of data and thus ensuring equivalent accuracy (Brookes et al., 2008).  The resulting 
pseudo-t-statistical images were used to derive the locations of the peak decrease in beta 
band oscillations in left motor cortex and the peak increase in gamma oscillations in visual 
cortex in each participant, which were used for further analyses (see Figures 1e and f for a 
representative example).  Note that since both peaks were identified from the active period 
contrasted with the baseline, the motor cortex (ERBD) peak was also used for analysis of the 
PMBR.  
 
Virtual sensor timecourses were constructed for these peak locations also using a 
beamformer spatial filter.  Beamforming was applied to data filtered into the 1-150Hz band 
and the covariance matrix was generated using data spanning the entire experiment.  The 
spatially filtered (virtual sensor) timecourses were sequentially filtered (temporally) into 23 
overlapping frequency bands in the range of 1-100Hz using a firls filter implemented in 
NUTMEG (http://nutmeg.berkeley.edu).  For each band, the Hilbert envelope was calculated 
and averaged across task trials.  A resting baseline signal was estimated as the mean Hilbert 
envelope within the 7.0-8.3s window, relative to stimulus onset, and the percentage 
difference in signal from this baseline was calculated across the trial averaged timeseries for 
all frequency bands.  These individual frequency bands were then concatenated to generate 
time frequency spectrograms, which were averaged across participants in the patient and 
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control groups (Figure 1).  The percentage change from baseline for the beta 
desynchronisation was taken from the 0.5-1.8s window, during which participants were 
moving, but which allowed time for participants to react to the stimulus onset.  The beta 
rebound signal was taken from the 2.3-4.3s window, based on the observed signal in a time 
frequency spectrogram averaged over all patients and controls.  In both cases a 13-30Hz 
frequency range was used.  To test gamma band amplitude in visual cortex, the percentage 
change from baseline was computed in the 30-70Hz frequency window in the 0.5-1.8s time 
window, in order to obtain only the sustained gamma response and not the initial gamma 
spike.  These data are shown in Figure 2.  Pseudo t-statistical images for Figure 1 were 
visualised using mri3dX (Singh, CUBRIC, Cardiff).  Statistical analysis was carried out in SPSS 
(Armonk, NY: IBM Corp.) and MATLAB (The Mathworks Inc., Natick, MA).  
 
3.  Results 
The task was well tolerated by all patients and controls.  Across all 46 participants, two 
patients and two controls failed to show a well localised beta desynchronisation peak in the 
motor cortex and one patient did not show a clear gamma peak in visual cortex.  These 
participants were excluded from analysis of these voxels, giving a total of 21 patients and 
controls contributing to analysis of motor beta, and 22 patients and 23 controls for visual 
gamma.   
 
 
 
12 
 
 
Figure 1: Time frequency spectrograms.  Percentage change from baseline in the trial-
averaged signal at the locations of individuals’ peak decrease in motor beta (a&b) and 
increase in visual gamma (c&d) during stimulation.  Data are averaged across controls (a&c) 
and patients (b&d).  Visual stimulation and motor responses were from 0-2s.  On the right 
are example pseudo t-statistical images from a single representative subject showing the 
spatial signature of the beamformed signal in the stimulus window (0.5-1.8s) contrasted 
with a baseline window (7-8.3s) in the beta (13-30Hz ) band (e) and gamma (30-70Hz) band 
(f). 
 
Figure 1 shows time frequency spectrograms, averaged across task trials and participants, 
for patients and controls at the motor and visual locations of interest.  Both groups exhibit 
the expected changes in oscillatory power in the beta and gamma bands throughout the 
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trial: in motor cortex, beta amplitude decreases during stimulation with a PMBR on 
movement cessation; and in visual cortex, there is a decrease in alpha oscillatory amplitude 
and a concomitant increase in gamma amplitude during stimulation.  As hypothesised, there 
were differences between patients and controls in features of these typical response 
profiles. 
 
 
Figure 2: Beta and gamma band responses.  Mean timecourse of beta band amplitude in 
motor cortex (a) and gamma band amplitude in visual cortex (b), measured as a percentage 
difference from baseline (7-8.3s); shaded areas show standard error of the mean (SEM) 
across participants. c) Mean percentage signal change from baseline in motor cortex during 
event-related beta desynchronisation (ERBD; 0.5-1.8s) and post-movement beta rebound 
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(PMBR; 2.3-4.3s); and in visual gamma oscillations during stimulation (0.5-1.8s).  Error bars 
represent SEM.   
 
Figures 2a and 2b show the timecourses of percentage signal change in oscillatory 
amplitude from baseline (7.0-8.3s) for the beta band (13-30Hz) in the motor cortex (a) and 
the gamma band (30-70Hz) in the visual cortex (b) for patients (red) and controls (blue).  The 
mean percentage changes during ERBD, PMBR and visual stimulation are shown in Figure 2c 
for both groups.  ERBD and visual gamma were measured in the 0.5-1.8s window, the PMBR 
was measured from 2.3-4.3s.  Note that the largest difference between patients and 
controls is in the PMBR, which shows a 30% increase from baseline in controls, and only a 
14% increase in patients. 
 
Interestingly, behavioural data indicated that on average, patients made more button 
presses per trial (mean 6.83 presses, between subjects standard deviation (SD) 2.18, within 
subjects SD 1.03) than controls (mean 5.27 presses, between subjects SD 2.02, within 
subjects 0.60).  This difference in these ‘button press counts’ was statistically significant 
(t(44)=-2.52; p=.016).  However, the mean time of the last button press in each trial was 
similar for patients (1.92s, SD 0.34) and controls (1.89s, SD 0.19) (U=33; p=.156).  These 
results indicate that on average, patients with schizophrenia pressed the button more 
frequently in the allocated time period than controls but not for longer; therefore patients 
tended to press faster than controls.  In order to investigate MEG data from groups with 
comparable behaviour, participants who pressed on average between four and eight times 
per trial were selected for initial analyses, based on the overlap of the distributions of 
button press counts from the two groups.  This criterion gave groups of 12 controls and 13 
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patients.  Responses from these subgroups are presented in Figure 3.  Note that the 
difference between groups in the PMBR remains, suggesting qualitatively that this effect is 
not simply accounted for by the different numbers of button presses in the two groups. 
 
 
Figure 3: Timecourses for groups with equivalent numbers of button presses.  Mean motor 
beta (a) and visual gamma (b) timecourses in groups of patients (red, N=12) and controls 
(blue, N=13) who made similar numbers of button presses (mean of 4-8 presses per trial).  
Shaded areas are SEM across participants. 
 
Statistical analysis of these behaviourally comparable data was conducted with a repeated 
measures analysis of variance (ANOVA), the results of which are shown in Table 3a.  This 
analysis indicated that when beta amplitude was summed across both stages of the 
response, patients showed a slightly lower amplitude response than controls.  However, the 
difference in beta amplitude between the groups was dependent on the stage (ERBD or 
PMBR) of the response, in that the two groups showed very similar ERBD but the PMBR was 
significantly reduced in patients.  As expected, the PMBR was significantly greater than the 
ERBD in both groups.  The difference in gamma amplitude between groups was analysed 
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using a Mann-Whitney  U-test, because these data were not normally distributed.  There 
was no significant difference in gamma amplitude in visual cortex between the two groups 
(U=83; p=.810).   
 
 
Table 3.  Results of a repeated measures ANOVA on beta amplitude in the subgroup with 
comparable behavioural responses (a), with the between subjects factor of group (patients 
and controls) and within subjects factor of beta stage (ERBD and PMBR).  The same 
contrasts but with the covariate of mean button press count are presented in the ANCOVA 
results, which includes data from all participants (b). 
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The difference between groups in the mean number of button presses made per trial (the 
button press count) warranted further investigation in relation to its impact on the MEG 
data from the full cohort of participants.  An analysis of covariance was therefore conducted 
on the beta responses of all participants with button press count included as a covariate.  
The results of this analysis are presented in Table 3b.  In this analysis, the overall difference 
between groups in the sum of beta amplitude across the two stages was not statistically 
significant; however, again there was a difference between the way in which the two groups 
responded at the two stages of the beta response (shown by the significant group by stage 
statistical interaction).  Follow-up univariate ANCOVAs conducted on each group separately 
and on each stage separately indicated that while the mean amplitudes of ERBD and PMBR 
were not significantly different between the groups, controls showed a significant increase 
from ERBD to PMBR (the peak-to-peak ‘beta difference’), irrespective of the number of 
button presses, whereas in patients, the beta difference was related to button press count: 
individuals who pressed the button more often showed a greater increase from ERBD to 
PMBR (correlation between beta difference and button press count R2=0.23; p=.029).  This 
effect can be observed in Figure 4, which shows that for patients in the lowest quartile of 
mean button press counts, there is little change between the two beta stages, but as button 
press count increases, the beta difference in patients increases and the timecourse becomes 
more similar to controls.  Controls show similar timecourses regardless of how many times 
they press the button (correlation of beta difference with button press count R2=0.02; 
p=.494).  Figure 4 again suggests that the PMBR is more affected by schizophrenia than 
ERBD; however there are insufficient numbers of participants to statistically test the group 
difference on the two stages across different button press counts.   
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Figure 4: Effect of number of button presses.  Mean beta timecourses for groups of patients 
(red) and controls (blue), defined by the quartiles of mean button press count across all 
volunteers, from lowest (a) to highest (d).  Shaded areas represent SEM across all trials. 
 
Visual gamma was analysed using a univariate ANCOVA with mean button presses as a 
covariate.  There was no significant difference between patients and controls’ visual gamma 
amplitude (F(1,41)=.08; p=.780) and the button press count did not influence visual gamma 
(main effect of button presses: F(1,41)=1.45; p=.236, and interaction between group and 
button presses: F(1,41)=.64; p=.428). 
 
To investigate the influence of medication on the electrophysiological measures obtained, in 
a separate analysis of only the patient group, defined daily dose (DDD (Methodology, 2012)) 
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of psychotropic medication was considered as an additional covariate in the contrast 
between beta stages.  Taking DDD into consideration did not alter the results: patients with 
lower button press counts showed a smaller beta difference than those with higher button 
press counts, regardless of their dose of antipsychotic medication (significant beta 
stage*button press count interaction (F(1,17)=5.04; p=.038); non-significant main effects of 
beta stage, button press count and DDD, and all other interactions between these variables 
(all F(1,17)<1.89); p>.187).  To assess the relationship between DDD and gamma, the 
correlation between 10,000 randomly paired gamma and DDD values was obtained, and the 
measured correlation was compared with the upper and lower 2.5% of values in the 
resulting distribution of correlations, to assess the probability of obtaining a correlation of 
the measured strength.  DDD did not relate significantly to gamma amplitude in patients 
(R=-0.07; p=ns; 95% CI [-0.367 and 0.486]).  These findings indicate that medication did not 
have a significant effect on motor beta or visual gamma oscillations.   
 
Scores of overall severity of persisting psychotic illness exhibited a significant negative 
Pearson correlation with the PMBR in the patient group (R=-0.52; p=.015; Figure 5), with no 
correlation between illness severity and ERBD or visual gamma (R=-.18 and .06 respectively; 
p=ns).  The scores for the three core syndromes of schizophrenia loaded positively on the 
illness severity measure, while social, occupational and cognitive function loaded negatively 
on it (see table 4), so those patients with higher severity scores had stronger core symptoms 
and lower levels of function.  These were also the patients who showed the smallest beta 
rebound. 
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Figure 5: Correlation between PMBR and severity of persisting psychotic illness.  The 
amplitude of the post-movement beta rebound showed a significant negative correlation 
with a measure of overall psychotic illness severity persisting during a stable phase of illness 
in the patient group. 
 
Illness severity measure Loading on severity of persisting illness factor 
Reality distortion 0.72 
Psychomotor poverty 0.61 
Disorganisation 0.58 
DSST -0.37 
SOFAS -0.67 
 
Table 4: Loadings on the first factor derived from factor analysis of clinical features 
hypothesised to reflect current severity of illness: reality distortion, psychomotor poverty and 
disorganisation syndromes from the Signs and Symptoms of Psychotic Illness (SSPI) scale 
(Liddle, 2002); and scores from the Digit Symbol Substitution Test (DSST; Wechsler, 1944) 
and the Social and Occupational Function Assessment Scale (SOFAS; APA, 1994). 
 
An additional interesting feature of the time-frequency spectrograms (Figure 1) was the 
apparent difference in theta oscillations between groups.  These were not part of our 
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hypothesis, but were contrasted in non-planned post-hoc comparisons of the stimulation 
period (0.5-1.8s).  Patients showed significantly reduced theta in motor cortex (U=78; 
p<.001), while the difference in visual cortex was not significant (t(43)=.62; p=.542). 
 
In summary, the results indicate that in groups of participants matched for performance on 
a self-paced button press task, the amplitude of post-movement beta oscillations is reduced 
in patients with schizophrenia compared with controls.  Beta reactivity, reflected in the 
change from the desynchronisation during movement to synchronisation following 
movement was reduced in patients who pressed the button less often.  Visual gamma did 
not differ significantly between groups.  Theta oscillations were reduced in patients’ motor 
but not visual cortex. 
 
4.  Discussion 
Deficits in sensorimotor function have been a well-established feature of schizophrenia 
since the earliest descriptions of the disease; however, despite their prevalence and impact, 
few studies have probed the neuronal mechanisms underlying these symptoms.  In this 
study, we measured the electrophysiological signature of visual and motor processing in 
patients with schizophrenia and matched healthy control subjects using MEG.  Our results 
show that the characteristic profiles of oscillatory responses to visual and motor stimulation 
are preserved in schizophrenia.  However, significant differences in neuronal dynamics are 
observed in patients relative to controls.  Specifically, the well-characterised temporal 
signature of beta oscillations in motor cortex during finger movement differs between the 
two groups: when matched for behaviour, patients showed a reduced PMBR, while their 
ERBD was relatively preserved.  Interestingly, patients who pressed the button infrequently 
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in our self-paced motor task showed significantly less of a difference between the ERBD and 
PMBR stages of the trial than those who pressed very rapidly.  Patients who pressed rapidly 
showed beta timecourses that were similar to controls, in whom clear ERBD and PMBR 
responses were present regardless of their mean button press count.  There was no 
significant difference in visual gamma oscillations between groups.  Our results therefore 
indicate abnormalities in basic sensorimotor processing in patients with schizophrenia. 
 
The differences in beta oscillatory response profiles between patients and controls provide 
a potential neuronal correlate of known motor disturbances in schizophrenia.  There are 
various theories as to the roles that beta desynchronisation and rebound play in the 
generation and inhibition of movement.  At rest, beta oscillations in motor cortex may 
control tonic contractions involved in maintenance of posture, while simultaneously 
inhibiting additional movements (Gilbertson et al., 2005).  Decreases in beta synchrony 
during or preceding a movement may therefore reflect a switch to a state in which a greater 
range of movements can be made, since reduced synchrony allows greater flexibility to 
encode information in cellular assemblies (McIntosh et al., 2008).  The increase in beta 
power following a movement has been suggested to reflect inhibition of motor activity: 
voluntary movements are slowed both during periods of beta oscillations as measured using 
electrocorticograms (Gilbertson et al., 2005), and when beta rhythms are entrained using 
transcranial alternating-current stimulation (Pogosyan et al., 2009).  This post-movement 
inhibition may facilitate motor control by preventing repetition or generation of further 
movements and returning postural stability.  Evidence for this theory comes from findings 
that the PMBR is almost absent in young children but increases through development (Gaetz 
et al., 2010); while in individuals with Parkinson’s disease whose movements are limited and 
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poorly controlled, both ERBD and PMBR are reduced in amplitude compared with controls 
(Heinrichs-Graham et al., 2014; Pollok et al., 2012).  Beta oscillations may also reflect long-
range communication between brain regions, whereas gamma oscillations reflect more local 
processing (Donner et al., 2011).  In the context of these theories, the reduced reactivity of 
motor cortex in schizophrenia observed in this study may reflect maintenance of tonic 
contractions and reduced flexibility of responses during movements; reduced inhibitory 
control allowing efficient termination of the movement; and/or limited ability to switch 
between long-range and local communication between neurons. 
 
Growing evidence suggests that both beta and gamma oscillations in the cortex depend 
upon a delicate balance between excitation and inhibition (Brunel et al., 2003; Kopell et al., 
2000), governed largely but not exclusively by glutamate and gamma-aminobutyric acid 
(GABA), which are the principal excitatory and inhibitory neurotransmitters, respectively.  
There is a large amount of evidence for disruption to this balance in schizophrenia caused by 
GABAergic abnormalities (Lewis, 2014; Rowland et al., 2008), including reductions in levels 
of GAD, the enzyme necessary for synthesis of GABA from glutamate, and in the mRNA that 
codes for GAD and for the GABA transporter and receptors (Shin et al., 2011).  There are 
also reductions in the volume of pyramidal neurons (Sweet et al., 2004) and in the number 
of parvalbumin expressing GABAergic inhibitory interneurons, which are involved in the 
generation of gamma oscillations (Lewis, 2014).  Deletion of a gene coding for a receptor for 
neuroregulin molecules, which are involved in regulating neuronal development in 
parvalbumin interneurons, causes reorganisation of cortical networks, increases oscillatory 
activity particularly in the gamma frequency and leads to schizophrenia-like symptoms 
including disruption of emotional and social behaviour and cognitive function in mice (Del 
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Pino et al., 2013).  Restoring normal levels of neuroregulin reverses these symptoms (Marin 
et al., 2013).  These animal studies strongly suggest a link between abnormalities in 
parvalbumin interneurons and schizophrenia. 
 
In contrast with previous findings (Grutzner et al., 2013; Shin et al., 2011; Spencer et al., 
2004; Sun et al., 2013), our study did not show significant reductions in gamma oscillations 
in the visual cortex of patients with schizophrenia, although the difference observed was in 
this direction.  The link between GABAergic inhibition and beta oscillations has been 
assessed by an in vitro study showing generation of beta oscillations in neuronal assemblies 
of cortical layer V (Roopun et al., 2006), a magnetic resonance spectroscopy (MRS) study 
showing a positive correlation between GABA and PMBR power (Gaetz et al., 2011) and a 
pharmacological study showing that blocking GABA uptake increases ERBD and decreases 
PMBR amplitude (Muthukumaraswamy et al., 2012).  Impaired GABAergic 
neurotransmission in schizophrenia may therefore contribute to the decrease in amplitude 
of beta oscillations observed in patients in our study. 
 
In patients, the difference between beta desynchronisation and rebound was greater and 
more similar to controls when they pressed the button at a faster rate (Figure 4).  PMBR in 
response to median nerve stimulation is reduced by ERBD generated during simultaneous 
movement, and this effect is greater as the amount of motor activity increases (e.g. passive 
stretch compared with exploratory finger movement (Salenius et al., 1997), or imagined 
compared with performed movement (Schnitzler et al., 1997)), but direct measurement of 
the effects of movement complexity or frequency on the movement-related beta response 
have not to our knowledge been reported.  The relative poverty of motor responses in some 
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of the patients with schizophrenia in this study may arise from the observed abnormalities 
in beta reactivity.  Such an effect could be due to impaired communication between motor 
cortex and higher order cortical regions, and/or to altered neurotransmission; however, 
these suggestions are speculative and would require further study using measures of 
functional connectivity and transmitter concentration or cycling rates.  On average, patients 
tended to exhibit a higher button press count compared with controls.  It is not clear why 
this was the case; it may represent a form of coping strategy, given that with higher button 
press counts, the beta timecourse became more similar to controls.  This behaviour 
somewhat masked abnormalities in beta oscillations that would likely have been more 
striking had only one button press been required.   
 
Use of a task with self-paced movements and subsequent analysis of data taking into 
consideration the button press count has revealed interesting differences in the beta 
oscillatory profiles between the two groups that would not otherwise have been evident.  
Another significant advantage of the paradigm presented here is that it is short, simple and 
is suitable for individuals of all cognitive abilities.  The ability to measure differences 
between patients with schizophrenia and controls in such a basic paradigm is promising for 
eventual translation of similar approaches into clinical practice.  This MEG approach, which 
permits investigation of neuronal activity within brain networks of patients and healthy 
volunteers, also reduces the need to conduct similar studies in animal models of mental 
health disorders. 
 
It is important to consider the effect of medication on the electrophysiological measures 
obtained in this study.  The patients were primarily taking antipsychotics, which inhibit 
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dopaminergic function (Castle et al., 2013) and some were taking antidepressants, which 
enhance serotonergic or noradrenergic mechanisms (Feighner, 1999).  Because dopamine 
has an inhibitory effect on cortical activity (Ciccone, 2015), antipsychotics tend to shift the 
balance of activity towards cortical excitation.  There is evidence from preclinical studies 
that chronic administration of antipsychotics can reduce steady state oscillatory power in 
the gamma frequency (Anderson et al., 2014), while non-invasive neuroimaging has shown 
enhanced steady state delta and theta but reduced alpha and beta amplitude after 
administration of antipsychotics in healthy volunteers (Galderisi et al., 1996; Hubl et al., 
2001).  The observation that taking into account patients’ daily dose of psychotropic 
medication did not alter the results, together with evidence from other studies indicating 
that oscillatory abnormalities are present in unmedicated patients with schizophrenia 
(Boutros et al., 2008; Gallinat et al., 2004; Sun et al., 2013) and in first degree relatives 
(Hong et al., 2012) suggests that the abnormalities observed in our study are unlikely to be 
attributable to medication.  Nevertheless, further investigation into the impact of 
medication on the responses measured in this study is warranted.   
 
The PMBR was inversely correlated with a score of overall severity of psychotic illness 
assessed during a stable phase of the illness.  The scores for the three core syndromes of 
schizophrenia loaded positively on the illness severity measure, while social, occupational 
and cognitive function loaded negatively on it (Table 4).  The magnitude of the DSST loading 
is lower than for the other items, but DSST score was retained because the set of items were 
selected a priori as a measure of illness severity (Palaniyappan et al., 2013) and a meta-
analysis of cognitive impairments in schizophrenia has shown that the DSST quantifies an 
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inefficiency of information processing that is an important feature of schizophrenia 
(Dickinson et al, 2007).   
 
Similar to previous studies (e.g. Liddle, 1987b), the three syndrome scores showed low 
mutual correlations (0.033 to 0.33; p<.05), but all three loaded heavily on a single factor, 
along with the SOFAS and DSST scores, indicating that they are associated with a latent 
variable likely to reflect severity of illness.  Scores on this composite measure of overall 
current severity of psychotic illness exhibited a significant negative Pearson correlation with 
the PMBR in the patient group (R=-0.52; p=.015; Figure 5), with no correlation between 
illness severity and ERBD or visual gamma (R=-.18 and .06 respectively; p=ns).  Therefore, 
those patients with higher severity scores had stronger core symptoms and lower levels of 
function and these were also the patients who showed the smallest beta rebound. 
 
In conclusion, abnormalities in perceptual processing and psychomotor performance are key 
aspects of the pathophysiology that influences functional outcome in schizophrenia (Boden 
et al., 2014; Javitt, 2009).  Electrophysiological biomarkers for these deficits can be 
identified using non-invasive neuroimaging techniques (Javitt et al., 2008) and they can be 
modified using targeted training (Adcock et al., 2009).  We have used a simple visuomotor 
task and MEG imaging to show abnormalities in the dynamics of beta oscillations in motor 
cortex, giving direct electrophysiological evidence to support theories of impaired cortical 
inhibition in schizophrenia.  Consistent with our current understanding of GABA-glutamate 
dysfunction in this illness, our findings raise the possibility of targeting the visuomotor 
system for behavioural training and pharmacological treatments in patients with 
schizophrenia. 
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